Dr. Shahzad Ahmad

Schar Chair, Advanced Lung Disease and Lung Transplant Medical Director, Advanced Lung Disease and Lung Transplant Program, Inova Schar Heart and Vascular Professor of Medical Education, University of Virginia, Inova CampusSteven D. Nathan, MD, FCCP, is the medical director of Inova’s Advanced Lung Disease Program and Lung Transplant Program. He is also a professor of medicine at the University of Virginia.Dr. Nathan is board certified in pulmonary diseases, critical care medicine and internal medicine. The author of more than 500 publications, Dr. Nathan is internationally recognized for his expertise in advanced lung diseases. He is co-editor of two books on idiopathic pulmonary fibrosis that provide pulmonologists and other healthcare workers with an up-to-date review of the background and advances in the field: Idiopathic Pulmonary Fibrosis and Guide to Clinical Management of Idiopathic Pulmonary Fibrosis. He also has written original research manuscripts, abstracts, reviews and book chapters. Dr. Nathan is a reviewer for multiple journals and is on the editorial board for the journal, Thorax. He has served on multiple committees, including U.S. Food and Drug Administration advisory boards as well as steering committees for clinical trials in IPF and pulmonary hypertension, where he has also served as chair. Dr. Nathan is a member of several professional medical associations, including the American Thoracic Society, the American College of Chest Physicians, and the International Society for Heart and Lung Transplantation. He has delivered talks and been chairperson of numerous sessions at many national and international conferences. Dr. Nathan is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Idiopathic Pulmonary Fibrosis, Acute Interstitial Pneumonia, Interstitial Lung Disease, Lung Transplant, and Prostatectomy. Dr. Nathan is currently accepting new patients.

Shambhu Aryal, MD, FCCP, serves as Medical Director for the Inova Lung Transplant Program and Inova Sarcoidosis Center. He is board certified in internal medicine, pulmonology and critical care, with expertise in lung transplantation, sarcoidosis, interstitial lung diseases, pulmonary hypertension and bronchiectasis. Dr. Aryal joined Inova in 2017 with several years of clinical experience, immediately following an assistant professorship at Duke University Hospital. Dr. Aryal says that helping patients get a second chance at life is the most fulfilling aspect of transplant pulmonology. His expertise in advanced lung disease management and transplantation equips him to provide the best possible medical care to patients with severe lung diseases. Additionally, he has served as a clinical investigator for many clinical trials in his areas of expertise. Originally from Nepal, Dr. Aryal resides in Northern Virginia with his wife and two boys. He enjoys time with his family, watching his sons' soccer and basketball games, and traveling. Dr. Aryal is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, and Lung Transplant. Dr. Aryal is currently accepting new patients.

Whitney Brown, MD, is director of Clinical Operations and medical director of the Cystic Fibrosis and Bronchiectasis Program at Inova Advanced Lung Disease and Transplant Program at Inova Fairfax Hospital. Dr. Brown has been with the Inova Advanced Lung Disease and Transplant Program since 2010. She is board certified in pulmonary disease, critical care medicine and internal medicine Dr. Brown has a special interest in idiopathic pulmonary fibrosis (IPF), lung transplant outcomes and the care of adult cystic fibrosis patients. She enjoys conducting outcomes-based research and has co-authored two original research articles on IPF, one on prognosis in IPF and the other on the impact of hospitalization on IPF. Dr. Brown is a member of the American Thoracic Society and the International Society for Heart and Lung Transplantation. Dr. Brown is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Acute Interstitial Pneumonia, Interstitial Lung Disease, Cystic Fibrosis, Lung Transplant, and Endoscopy. Dr. Brown is currently accepting new patients.

Dr. Amit Mahajan is the Medical Director of interventional pulmonology at Inova Health System. He is board certified in interventional pulmonology, pulmonary medicine and critical care medicine. Dr. Mahajan completed his interventional pulmonology fellowship at Harvard Hospital System’s Interventional Pulmonology Program. Dr. Mahajan’s areas of expertise include procedures for diagnosing lung cancer, treating cancers within the airways, management of airway complications following lung transplantation, and bronchoscopic lung volume reduction (BLVR) for patients with severe emphysema. Additionally, Dr. Mahajan oversees Inova’s incidental lung nodule program and lung cancer screening program. Dr. Mahajan is nationally recognized as a leader in interventional pulmonology and has served on the board of directors for the American Association of Bronchoscopy and Interventional Pulmonology (AABIP) and the American Association of Respiratory Care (AARC). He has also been recognized as a Top Doctor for Washingtonian Magazine. Dr. Mahajan is a native of Toledo, OH, and currently resides in Vienna, VA, with his wife and three children. Dr. Mahajan is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Lung Nodules, Lymphofollicular Hyperplasia, Lung Cancer, Endoscopy, and Advanced Bronchoscopy. Dr. Mahajan is currently accepting new patients.

Dr. Christopher S. King is a transplant pulmonologist and the Chief of Cardiovascular Critical Care at Inova Fairfax Hospital. He also serves as the Associate Medical Director of the Transplant and Advanced Lung Disease Program, Director of the Cardiovascular Intensive Care Unit at Inova Fairfax Hospital, the Pulmonary Fibrosis Foundation Center Director, and System Director of Respiratory Care Services for Inova. Dr. King is board certified in internal medicine, pulmonary medicine and critical care medicine. Dr. King serves as both a transplant pulmonologist and a medical intensivist for the medical critical care service at Inova Fairfax Hospital. He is also an Associate Clinical Professor of Medicine for the University of Virginia School of Medicine. Dr. King is a member of the medical honor society, Alpha Omega Alpha. While on active duty in the United States Army, he completed tours in Korea and Afghanistan as well as serving in Virginia and Texas. Dr. King has participated in clinical research throughout his training and during his tenure at Inova. His research interests are broad and include venous thromboembolism, interstitial lung disease and pulmonary hypertension. He has coauthored numerous publications including original research and review articles. He has lectured at national conferences and currently serves as a panel member for the American College of Chest Physicians' guidelines on antithrombotic disease. Dr. King is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Acute Interstitial Pneumonia, Hypersensitivity Pneumonitis, Pulmonary Veno-Occlusive Disease, and Pulmonary Hypertension. Dr. King is currently accepting new patients.

Anju Singhal is a Pulmonary Medicine provider practicing medicine in Falls Church, Virginia. She has been practicing medicine for over 17 years. Dr. Singhal is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Interstitial Lung Disease, Acute Interstitial Pneumonia, Lung Metastases, Pneumonia, and Lung Transplant. Dr. Singhal is currently accepting new patients.